Italia markets open in 4 hours 57 minutes

Dow Jones
39.806,77
-196,82(-0,49%)
Nasdaq
16.794,88
+108,91(+0,65%)
Nikkei 225
39.188,60
+118,92(+0,30%)
EUR/USD
1,0858
-0,0004(-0,03%)
Bitcoin EUR
65.476,71
+4.203,34(+6,86%)
CMC Crypto 200
1.512,19
+157,77(+11,65%)

NBIX May 2024 125.000 call

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

11,40

0,00

(0,00%)

In data: 03:54PM EDT. Mercato aperto.

GlobeNewswire
Sosei Heptares’ partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults
NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNBI-1117570 is the second compound to advance into clinical development from a portfolio of selective muscarinic receptor agonists licensed by Sosei Heptares to Neurocrine following NBI-1117568, an oral, selective muscarinic M4 receptor agonist, which is in Phase 2 clinical trials as an investigational treat